Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK

BACKGROUND: Myeloma is an incurable life-threatening hematological cancer. Recent treatment developments have seen improvements in survival; however, while patients are living longer, they are living with symptoms and treatment side effects. OBJECTIVE: To evaluate myeloma patients’ preferences for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fifer, Simon, Galinsky, Jayne, Richard, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395685/
https://www.ncbi.nlm.nih.gov/pubmed/32801659
http://dx.doi.org/10.2147/PPA.S259612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395685/
https://www.ncbi.nlm.nih.gov/pubmed/32801659
http://dx.doi.org/10.2147/PPA.S259612

Ejemplares similares